0000899243-20-000884.txt : 20200109
0000899243-20-000884.hdr.sgml : 20200109
20200109163302
ACCESSION NUMBER: 0000899243-20-000884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200107
FILED AS OF DATE: 20200109
DATE AS OF CHANGE: 20200109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Katkin Keith
CENTRAL INDEX KEY: 0001314596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20518520
MAIL ADDRESS:
STREET 1: C/O PENINSULA PHARMACEUTICALS, INC.
STREET 2: 1751 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-07
0
0001740547
Urovant Sciences Ltd.
UROV
0001314596
Katkin Keith
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVENUE, SUITE 100
IRVINE
CA
92617
1
1
0
0
PEO;CEO/Urovant Sciences, Inc.
Common Shares
2020-01-07
4
A
0
199680
0.00
A
199680
D
25% of the Restricted Stock Units shall vest on January 7, 2021; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
/s/ Bryan Smith, Attorney-in-Fact
2020-01-09